Drug Shortage Report for PAMIDRONATE DISODIUM FOR INJECTION

Last updated on 2019-05-30 History
Report ID 83361
Drug Identification Number 02244552
Brand name PAMIDRONATE DISODIUM FOR INJECTION
Common or Proper name PAMIDRONATE
Company Name PFIZER CANADA ULC
Active Ingredient(s) PAMIDRONATE DISODIUM
Strength(s) 9MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10ML Vial
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-05-10
Estimated end date 2019-09-30
Actual end date
Shortage status Actual shortage
Updated date 2019-05-30
Company comments Other presentations are available
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-05-30 French Compare
v6 2019-05-30 English Compare
v5 2019-05-23 French Compare
v4 2019-05-23 English Compare
v3 2019-05-11 English Compare
v2 2019-05-07 French Compare
v1 2019-05-07 English Compare